rct
    2016

    Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor: a randomized, double-blind, placebo-controlled, multicenter North American clinical trial

    Jensen GS, Lenninger M, Ero MP, Benson KF

    Published in Integrated Blood Pressure Control

    Key Findings

    Nattokinase 100 mg/day lowered systolic and diastolic blood pressure in men and reduced von Willebrand factor over eight weeks.

    Conclusions

    Blood pressure effect was sex-dependent.

    Limitations

    Modest sample, subgroup-driven results.

    Supplements Studied

    Nattokinase lowered blood pressure in men and reduced von Willebrand factor over eight weeks.

    Study Details

    Year:2016
    Sample Size:79
    Duration:8 weeks
    Quality Score:6/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.